Lexicon Pharmaceuticals Inc share price logo

Lexicon Pharmaceuticals Inc

NASDAQ: LXRX

Small Cap

$1.95

-0.12

(-5.80%)

Live

as on

Lexicon Pharmaceuticals Inc Stock Performance

as on June 3, 2026 at 3:49 am IST

  • Day's Low

    Day's High

    $1.94
    $2.09
    downward going graph

    0.51%

    Downside

    7.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.62
    $2.53
    downward going graph

    68.46%

    Downside

    29.74%

    Upside

    downward going graph

Lexicon Pharmaceuticals Inc share price movements today

Previous Close
$2.07
Open
$2.09
Volume
2.5M
Day's Low - High
$1.94 - $2.09
52 Week Low - High
$0.62 - $2.53

Lexicon Pharmaceuticals Inc Historical Returns

1 Month Return
+ 26.99 %
3 Month Return
+ 32.69 %
1 Year Return
+ 233.01 %
3 Year Return
-24.59 %
5 Year Return
-54.9 %

Lexicon Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Lexicon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$968.3M

EPS (TTM)

-0.1587

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

0

PEG Ratio

-0.14

EBITDA

-23.7M

Revenue (TTM)

69.6M

Profit Margin

-37.46%

Return On Equity TTM

-16.01%

Lexicon Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lexicon Pharmaceuticals Inc image
Lexicon Pharmaceuticals Inc
BUY$968.3M-54.9%NA-37.46%NA
Revolution Medicines Inc image
Revolution Medicines Inc
BUY$33.5B434.2%NA0.00%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.3B106.95%75.6812.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.6B108.38%26.5335.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$64.5B18.86%15.0229.65%0.58%

Stock Returns calculator for Lexicon Pharmaceuticals Inc Stock including INR - Dollar returns

The Lexicon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexicon Pharmaceuticals Inc investment value today

Current value as on today

₹3,51,039

Returns

₹2,51,039

(+251.04%)

Returns from Lexicon Pharmaceuticals Inc Stock

₹2,14,516 (+214.52%)

Dollar Impact

₹36,523 (+36.52%)

Analyst Recommendation on Lexicon Pharmaceuticals Inc Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals Inc. Average target price of $3.72

Lexicon Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals Inc.

What analysts predicted

47.58%UPSIDE

Target Price

$3.72

Current Price

$1.95

Analyzed by

11 Analysts

Target

$3.72

Lexicon Pharmaceuticals Inc target price $3.72, a slight upside of 47.58% compared to current price of $1.95. According to 11 analysts rating.

Indian Investors' Interest in Lexicon Pharmaceuticals Inc Stock

Search interest for Lexicon Pharmaceuticals Inc Stock has increased by 158% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:158% versus previous 30 day period

Lexicon Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
1
1
1
26
1
28
14
5
21
Gross Profit
-14
0
1
1
0
1
28
14
5
20
Operating Income
-46
-45
-55
-63
-32
-25
3
-12
-14
0
EBITDA
-45
-44
-51
-60
-20
-23
5
-10
-14
0
Interest Expense
5
4
2
4
3
1
2
2
2
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-49
-48
-53
-64
-33
-25
3
-12
-15
-1
Income Tax Expense
-2
0
-
-
0
-
-
-
-
-
Net Income
-49
-48
-53
-64
-33
-25
3
-12
-15
-1
Net Profit Margin
-7087.75%
-4282.92%
-3244.02%
-3703.49%
-127.16%
-2004.36%
11.27%
-90.04%
-282.72%
-4.94%

Lexicon Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
83
90
63
322
23
0
0
1
31
49
Gross Profit
-80
88
60
318
22
-54
-52
-57
30
49
Operating Income
-137
-136
-103
141
-47
-87
-100
-171
-197
-48
EBITDA
-125
-125
-96
148
-41
-86
-100
-169
-184
-48
Interest Expense
6
6
20
20
14
0
2
13
15
8
Depreciation
-
3
3
3
2
0
0
0
0
0
Income Before Tax
-141
-141
-120
124
-58
-87
-101
-177
-200
-50
Income Tax Expense
4
-12
3
-6
11
0
1
0
-200
-
Net Income
-141
-129
-120
130
-58
-87
-101
-177
-200
-50
Net Profit Margin
-169.71%
-142.86%
-190.71%
40.40%
-244.11%
-29448.99%
-73341.01%
-14710.88%
-644.78%
-101.08%

Lexicon Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-48
-53
-64
-33
-25
3
-12
-15
-1
Operating Cash Flow
-55
-48
-53
-21
-43
16
-23
-17
-14
Investing Cash Flow
-110
-12
53
53
40
15
52
4
-70
Financing Cash Flow
239
0
0
0
0
-45
-
-2
88
Change in Cash
74
-60
-1
32
-3
-12
28
-15
3

Lexicon Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-129
-120
130
-58
-87
-101
-177
-200
-50
Operating Cash Flow
-185
-148
113
-142
-87
-88
-161
-178
-67
Investing Cash Flow
50
169
-155
380
2
-71
-49
-15
113
Financing Cash Flow
149
-2
-2
-147
22
142
187
238
-48
Change in Cash
15
18
-44
90
-62
-17
-23
44
-3

Global Institutional Holdings in Lexicon Pharmaceuticals Inc

Funds
Holdings
Susquehanna International Group, LLP
0.48%
HRT FINANCIAL LLC
0.13%
Geode Capital Management, LLC
0.71%
Sessa Capital IM LP
0.83%
Marshall Wace Asset Management Ltd
0.28%
See all

Insights on Lexicon Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 5.49M → 21.10M (in $), with an average increase of 74.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -15.53M → -1.04M (in $), with an average increase of 1389.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LXRX stock has moved up by 27.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 540.1% return, outperforming this stock by 564.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 302.7% return, outperforming this stock by 69.7%

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
OrganisationLexicon Pharmaceuticals Inc
Headquarters2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381
IndustryBiotechnology
CEODr. Michael S. Exton Ph.D.
E-voting on sharesClick here to vote

Key Management of Lexicon Pharmaceuticals Inc

Name

Title

Dr. Michael S. Exton Ph.D.

CEO & Director

Mr. Scott M. Coiante

Senior VP & CFO

Ms. Lisa M. DeFrancesco

Senior Vice President of Investor Relations & Corporate Communications

Dr. Suma Gopinathan M.S., Ph.D.

Senior Vice President of Discovery

Ms. Rachel Yap Martens

Senior VP of Partnerships & Corporate Strategy

Mr. Brian T. Crum

Senior VP, General Counsel & Secretary

Ms. Wendy E. McDermott

Senior Vice President of Human Resources

Dr. Craig B. Granowitz M.D., Ph.D.

Senior VP & Chief Medical Officer

Ms. Kristen L. Alexander

Vice President of Finance & Accounting

FAQs

What is Lexicon Pharmaceuticals Inc share price today?

Lexicon Pharmaceuticals Inc share price today is $1.95 as on . Lexicon Pharmaceuticals Inc share today touched a day high of $2.09 and a low of $1.94.

What is the 52 week high and 52 week low for Lexicon Pharmaceuticals Inc share?

Lexicon Pharmaceuticals Inc share touched a 52 week high of $2.53 on and a 52 week low of $0.62 on . Lexicon Pharmaceuticals Inc stock price today i.e. is trending at $1.95,which is 22.92% down from its 52 week high and 217.07% up from its 52 week low.

What is Lexicon Pharmaceuticals Inc's market capitalisation today?

Lexicon Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Lexicon Pharmaceuticals Inc Stock (LXRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lexicon Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lexicon Pharmaceuticals Inc Shares that will get you 0.7692 shares as per Lexicon Pharmaceuticals Inc share price of $1.95 per share as on June 2, 2026 at 10:19 pm IST.

What is the minimum amount required to buy Lexicon Pharmaceuticals Inc Stock (LXRX) from India?

Indian investors can start investing in Lexicon Pharmaceuticals Inc (LXRX) shares with as little as ₹95.265 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.65 in Lexicon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Lexicon Pharmaceuticals Inc share’s latest price of $1.95 as on June 2, 2026 at 10:19 pm IST, you will get 5.1282 shares of Lexicon Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Lexicon Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Lexicon Pharmaceuticals Inc stock has given -54.9% share price returns and 30.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?